世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

化学療法誘発性吐き気・嘔吐（CINV）治療薬産業調査レポート 2024年


Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Research Report 2024

当レポートは、化学療法誘発性吐き気・嘔吐（CINV）治療薬の世界市場を量的および質的分析により包括的に提示し、読者が事業/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
APO Research
エーピーオーリサーチ 		2024年2月25日 US$2,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		90 138 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

当レポートは、化学療法誘発性吐き気・嘔吐（CINV）治療薬の世界市場を量的および質的分析により包括的に提示し、読者が事業/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、化学療法誘発性吐き気・嘔吐（CINV）治療薬に関する十分な情報に基づいたビジネス上の意思決定を行えるようにすることを目的としています。
化学療法誘発性吐き気・嘔吐（CINV）治療薬の市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データを考慮し、販売量（K単位）と収益（百万ドル）で提供されます。当レポートでは、世界の化学療法誘発性吐き気・嘔吐（CINV）薬市場を包括的にセグメント化しています。製品タイプ別、用途別、プレイヤー別の地域別市場規模も掲載しています。COVID-19とロシア・ウクライナ戦争の影響は市場規模を推定する際に考慮した。
市場のより詳細な理解のために、本レポートは競合状況、主要競合企業のプロフィール、それぞれの市場ランクを提供している。また、技術動向や新製品開発についても論じています。
本レポートは、化学療法誘発性吐き気・嘔吐（CINV）治療薬メーカー、新規参入企業、本市場における産業チェーン関連企業に対し、企業別、製品タイプ別、用途別、地域別の市場全体およびサブセグメント別の収益、販売量、平均価格に関する情報を提供します。
主要企業と市場シェアの洞察
このセクションでは、読者は競合する主要企業について理解を深めることができる。本レポートでは、革新的な動向や開発、製品ポートフォリオの強化、M&A、提携、新製品の革新、地理的拡大など、参入企業が存在感を維持するために行っている主要な成長戦略を調査している。事業戦略の他に、本調査には現在の開発状況や主要財務情報も含まれている。読者はまた、2019年から2024年までのメーカー別の世界的な収益、価格、販売に関するデータにアクセスすることができます。この包括的なレポートは、顧客が最新情報を入手し、ビジネスにおいて効果的な意思決定を行うのに役立つことは間違いない。調査レポートでレビューされている著名なプレーヤーは以下の通りです：
メルク
エーザイ
ムンディファーマ
Qiluファーマ
テバ
ノバルティス
ヘロン・セラピューティクス
ロシュ
マイラン
テサロ
製品タイプ別インサイト
世界市場を化学療法誘発性吐き気・嘔吐（CINV）治療薬のタイプ別に、2030年までの成長予測とともに紹介する。売上高と収益の推計は、化学療法誘発性吐き気・嘔吐（CINV）治療薬がメーカーから調達されるサプライチェーンにおける価格に基づいています。
本レポートでは、各セグメントを調査し、過去のデータを用いて市場規模を提供しています。また、各セグメントが将来もたらすであろう成長機会についても触れています。本調査では、タイプ別、過去期間（2019-2024年）および予測期間（2025-2030年）の売上高および収益データを提供する。
化学療法誘発性吐き気・嘔吐（CINV）治療薬のタイプ別セグメント
5-HT3阻害剤
NK1阻害薬
その他
アプリケーションインサイト
本レポートでは、過去期間（2019-2024年）および予測期間（2025-2030年）におけるアプリケーション別の市場規模（売上高および収益データ）を掲載しています。
また、化学療法誘発性吐き気・嘔吐（CINV）治療薬市場に影響を与える各セグメントの市場動向や消費者行動について概説し、これらが業界の将来にどのような影響を及ぼす可能性があるかについても記載しています。本レポートは、化学療法誘発性吐き気・嘔吐（CINV）治療薬市場を牽引している関連市場および消費者動向の理解に役立ちます。
化学療法誘発性吐き気・嘔吐（CINV）治療薬の用途別セグメント
催吐性の高い化学療法
中等度催吐性化学療法
催吐性の低い化学療法
その他
地域別展望
本セクションでは、様々な地域と各地域で事業を展開する主要企業に関する主要な洞察を提供する。経済的、社会的、環境的、技術的、政治的要因は、特定の地域/国の成長を評価する際に考慮されています。読者はまた、2019年から2030年までの各地域・国の収益・販売データを手にすることができる。
市場は、北米、欧州、アジア太平洋、南米、中東・アフリカを含む様々な主要地域に区分されている。米国、ドイツ、英国、イタリア、フランス、中国、日本、韓国、東南アジア、インドなどの主要国の詳細な分析は、地域セグメント内でカバーされます。市場推計については、2023年を基準年として、2024年の推計値、2030年の予測収益を提供する予定である。
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
主な推進要因と障壁
本レポートでは、読者が一般的な発展を理解するのに役立つよう、影響力の大きいレンダリング要因とドライバーを調査している。さらに、プレイヤーの行く手を阻む阻害要因や課題も含まれています。これは、ユーザーが気を配り、ビジネスに関連する情報に基づいた意思決定を行うのに役立ちます。また、専門家は今後のビジネス展望にも焦点を当てている。
COVID-19とロシア・ウクライナ戦争の影響力分析
このセクションの読者は、化学療法誘発性吐き気・嘔吐（CINV）薬市場のシナリオがパンデミック、ポストパンデミック、ロシア・ウクライナ戦争中に世界中でどのように変化したかを理解することができます。この調査は、需要、消費、輸送、消費者行動、サプライチェーン管理、輸出入、生産などの側面の変化を視野に入れて行われます。また、業界の専門家は、今後数年間、プレーヤーに機会を創出し、業界全体を安定させるのに役立つ主要因を強調しています。
本レポートを購入する理由
本レポートは、読者が潜在的な利益を高めるために、業界内の競争と競争環境の戦略を理解するのに役立ちます。また、世界の化学療法誘発性吐き気・嘔吐（CINV）治療薬市場の競争環境に焦点を当て、主要企業の市場シェア、業界ランキング、競合他社のエコシステム、市場実績、新製品開発、経営状況、事業拡大、買収などを詳細に紹介し、読者が主要競合企業を特定し、市場の競争パターンを深く理解するのに役立ちます。
本レポートは、関係者が化学療法誘発性吐き気・嘔吐（CINV）治療薬の世界的な産業状況と動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。
本レポートは、利害関係者が競合他社をよりよく理解し、事業における地位を強化するためのより多くの洞察を得るのに役立ちます。競争環境のセクションには、市場シェアと順位（数量と金額）、競合他社のエコシステム、新製品開発、拡大、買収などが含まれます。
本レポートは、斬新な技術統合、機能、市場の最新動向を常に更新しています。
本レポートは、関係者がCOVID-19およびロシア・ウクライナ戦争が化学療法誘発性吐き気・嘔吐（CINV）治療薬産業に及ぼす影響を理解するのに役立ちます。
本レポートは、ステークホルダーが世界的にどの地域をターゲットにすべきかを洞察するのに役立ちます。
本レポートは、関係者が化学療法誘発性吐き気・嘔吐（CINV）治療薬の採用に関するエンドユーザーの認識について洞察するのに役立ちます。
本レポートは、関係者が市場の主要プレイヤーを特定し、その貴重な貢献を理解するのに役立ちます。
コアチャプター
第1章：調査目的、調査方法、データソース、データの相互検証
第2章： レポートのスコープ、各市場セグメント（地域別、製品タイプ別、用途別など）のエグゼクティブサマリー、各市場セグメントの市場規模、今後の発展可能性などを紹介。市場の現状と、短期・中期・長期的にどのような進化を遂げる可能性があるのかについて、ハイレベルな見解を提供しています。
第3章：化学療法誘発性吐き気・嘔吐（CINV）治療薬メーカーの競争環境、価格、生産量、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。
第4章：主要企業のプロファイルを提供し、製品の生産/生産量、価値、価格、粗利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。
第5章 化学療法誘発性吐き気・嘔吐（CINV）治療薬の地域別/国別の生産/生産量、金額。今後6年間の各地域の市場規模と発展可能性を定量的に分析しています。
第6章 化学療法誘発性吐き気・嘔吐（CINV）治療薬の地域レベルおよび国レベルでの消費量。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、将来の発展展望、市場空間、生産量を紹介しています。
第7章：様々な市場セグメントを種類別に分析し、各市場セグメントの市場規模と発展可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ。
第8章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第9章：産業の上流と下流を含む産業チェーンの分析。
第10章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第11章：レポートの要点と結論。


ページTOPに戻る


目次

1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size (2019-2030) & (US$ Million)
2.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (2019-2030)
2.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Average Price (2019-2030)
2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Other
2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Highly Emetogenic Chemotherapy
2.4.3 Moderately Emetogenic Chemotherapy
2.4.4 Low Emetogenic Chemotherapy
2.4.5 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue of Manufacturers (2019-2024)
3.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Price by Manufacturers (2019-2024)
3.5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Product Type & Application
3.8 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Date of Enter into This Industry
3.9 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.1.5 Merck Recent Developments
4.2 Eisai
4.2.1 Eisai Company Information
4.2.2 Eisai Business Overview
4.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.2.5 Eisai Recent Developments
4.3 Mundipharma
4.3.1 Mundipharma Company Information
4.3.2 Mundipharma Business Overview
4.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.3.5 Mundipharma Recent Developments
4.4 Qilu Pharma
4.4.1 Qilu Pharma Company Information
4.4.2 Qilu Pharma Business Overview
4.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.4.5 Qilu Pharma Recent Developments
4.5 Teva
4.5.1 Teva Company Information
4.5.2 Teva Business Overview
4.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.5.5 Teva Recent Developments
4.6 Novartis
4.6.1 Novartis Company Information
4.6.2 Novartis Business Overview
4.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.6.5 Novartis Recent Developments
4.7 Heron Therapeutics
4.7.1 Heron Therapeutics Company Information
4.7.2 Heron Therapeutics Business Overview
4.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.7.5 Heron Therapeutics Recent Developments
4.8 Roche
4.8.1 Roche Company Information
4.8.2 Roche Business Overview
4.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.8.5 Roche Recent Developments
4.9 Mylan
4.9.1 Mylan Company Information
4.9.2 Mylan Business Overview
4.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.9.5 Mylan Recent Developments
4.10 Tesaro
4.10.1 Tesaro Company Information
4.10.2 Tesaro Business Overview
4.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.10.5 Tesaro Recent Developments
5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Scenario by Region
5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2019-2030
5.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2019-2024
5.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2025-2030
5.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2019-2030
5.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2019-2024
5.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2025-2030
5.4 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.4.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2030)
5.4.3 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.5.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2030)
5.5.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.6.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2030)
5.6.3 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.7.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2030)
5.7.3 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.8.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2030)
5.8.3 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2019-2030)
6.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2019-2030) & (K Units)
6.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2019-2030)
6.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2019-2030)
6.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2019-2030)
6.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2019-2030)
7 Segment by Application
7.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2019-2030)
7.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2019-2030) & (K Units)
7.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2019-2030)
7.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2019-2030)
6.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2019-2030)
7.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value Chain Analysis
8.1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Mode & Process
8.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
8.2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers
9 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Analyzing Market Dynamics
9.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Trends
9.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Drivers
9.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Opportunities and Challenges
9.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer

　

ページTOPに戻る


　

Summary

This report aims to provide a comprehensive presentation of the global market for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotherapy Induced Nausea and Vomiting (CINV) Drugs.
The Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
Product Type Insights
Global markets are presented by Chemotherapy Induced Nausea and Vomiting (CINV) Drugs type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs segment by Type
5-HT3 Inhibitors
NK1 Inhibitors
Other
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market.
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs segment by Application
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size (2019-2030) & (US$ Million)
2.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (2019-2030)
2.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Average Price (2019-2030)
2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Other
2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Highly Emetogenic Chemotherapy
2.4.3 Moderately Emetogenic Chemotherapy
2.4.4 Low Emetogenic Chemotherapy
2.4.5 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue of Manufacturers (2019-2024)
3.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Price by Manufacturers (2019-2024)
3.5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Product Type & Application
3.8 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Date of Enter into This Industry
3.9 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.1.5 Merck Recent Developments
4.2 Eisai
4.2.1 Eisai Company Information
4.2.2 Eisai Business Overview
4.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.2.5 Eisai Recent Developments
4.3 Mundipharma
4.3.1 Mundipharma Company Information
4.3.2 Mundipharma Business Overview
4.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.3.5 Mundipharma Recent Developments
4.4 Qilu Pharma
4.4.1 Qilu Pharma Company Information
4.4.2 Qilu Pharma Business Overview
4.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.4.5 Qilu Pharma Recent Developments
4.5 Teva
4.5.1 Teva Company Information
4.5.2 Teva Business Overview
4.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.5.5 Teva Recent Developments
4.6 Novartis
4.6.1 Novartis Company Information
4.6.2 Novartis Business Overview
4.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.6.5 Novartis Recent Developments
4.7 Heron Therapeutics
4.7.1 Heron Therapeutics Company Information
4.7.2 Heron Therapeutics Business Overview
4.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.7.5 Heron Therapeutics Recent Developments
4.8 Roche
4.8.1 Roche Company Information
4.8.2 Roche Business Overview
4.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.8.5 Roche Recent Developments
4.9 Mylan
4.9.1 Mylan Company Information
4.9.2 Mylan Business Overview
4.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.9.5 Mylan Recent Developments
4.10 Tesaro
4.10.1 Tesaro Company Information
4.10.2 Tesaro Business Overview
4.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
4.10.5 Tesaro Recent Developments
5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Scenario by Region
5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2019-2030
5.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2019-2024
5.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2025-2030
5.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2019-2030
5.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2019-2024
5.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2025-2030
5.4 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.4.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2030)
5.4.3 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.5.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2030)
5.5.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.6.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2030)
5.6.3 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.7.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2030)
5.7.3 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
5.8.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2030)
5.8.3 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2019-2030)
6.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2019-2030) & (K Units)
6.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2019-2030)
6.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2019-2030)
6.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2019-2030)
6.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2019-2030)
7 Segment by Application
7.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2019-2030)
7.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2019-2030) & (K Units)
7.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2019-2030)
7.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2019-2030)
6.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2019-2030)
7.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value Chain Analysis
8.1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Mode & Process
8.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
8.2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers
9 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Analyzing Market Dynamics
9.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Trends
9.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Drivers
9.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Opportunities and Challenges
9.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

APO Research社のPharma & Healthcare分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


APO Research社はどのような調査会社ですか?


 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22　10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.